1. RMANY
  2. About
  3. Success Rates

IVF Success Rates at RMA of New York

RMA of New York continues to be globally recognized as one of the world’s leading fertility clinics and IVF centers. By utilizing the most advanced technologies at our state-of-the-art facilities, such as preimplantation genetic testing (PGT), our expert team of physicians and embryologists has successfully facilitated the births of thousands of healthy babies throughout New York City, Westchester, Long Island, and beyond. We are proud to share our IVF success rate results as reported by the Society for Assisted Reproductive Technology (SART).

SART - Final Clinic Summary Report for 2020

To learn more about our IVF success rates, you can speak with an RMA of New York fertility clinic physician or member of our care team. We have a total of 14 fertility clinics in the NYC metropolitan area, including locations in Manhattan (Eastside, Westside, Downtown), Brooklyn, Westchester, and Long Island. Learn more about our fertility clinic locations.

What is My Chance of Getting Pregnant Using IVF Treatment?

Patients often want to understand their chance of getting pregnant when using IVF to build their families, as well as the various factors influencing pregnancy success. Several factors influence fertility treatment success rates, most notably a woman’s age and ovarian reserve (the quantity and quality of eggs in the ovaries). Additional factors include medical conditions, genetic factors, uterine abnormalities and conditions, as well as sperm quality, among other fertility health factors. Thankfully with advancements in assisted reproductive technologies (ART), such as preimplantation genetic testing (PGT) of embryos, the ability to overcome these obstacles and have a successful pregnancy outcome has never been higher. To further increase the likelihood of pregnancy success with IVF treatment, it is important to choose a fertility clinic with a top embryology laboratory and a track record of success, including favorable IVF success rates as reported by SART (the Society for Assisted Reproductive Technology).

What is SART?

The Society for Assisted Reproductive Technology (SART) is a professional organization that collects data from IVF clinics to provide essential data on fertility treatment. SART works closely with the Centers for Disease Control and Prevention (CDC) to verify and publish pregnancy data on IVF clinics in the United States annually. This data provides patients with reliable information on the likelihood of success with different treatment options.

RMA of New York – Live Births Per New Patient Compared with National Average

What is the chance of live birth doing IVF as a new patient in a clinic?

Live Births Per New Patient: Patient's Own Egg

Live Birth Rates: RMA of New York vs. National Average

Patient AgeLive Birth Rate: RMA of New YorkLive Birth Rate: National Average
< 3576.6%68.5%
35-3771.1%58.9%
38-4060.6%42.6%
41-4235.4%23.5%
> 4210.9%7.1%

* Source: SART
Results for RMA of New York. A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches, and entry criteria for assisted reproductive technology (ART) may vary from clinic to clinic.

Live Birth Rate Per Intended Egg Retrieval (All Embryo Transfers)

Live Births Per Intended Egg Retrieval (All Embryo Transfers)

Age of Women<3535 - 3738 - 4041 - 42>42
Live Births63.7%53.0%41.3%20.6%7.1%
Number of cycle starts510468460243210
Singleton Births63.7%53.0%41.3%20.6%7.1%

SART Data: RMA of New York Final Clinic Summary Report for 2021

A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches, and entry criteria for assisted reproductive technology (ART) may vary from clinic to clinic.

2021: 6,239 Total Cycles

  • What is the chance of live birth doing IVF as a new patient in a clinic?
    Age of Women<3535 - 3738 - 4041 - 42>42
    Live Births76.6%71.1%60.6%35.4%10.9%
    Number of thaw procedures38929125911392
    Singleton Births75.8%70.8%59.1%34.5%10.9%
  • What is the chance of live birth with an intended egg retrieval and the first embryo transfer, if any?
    Age of Women<3535 - 3738 - 4041 - 42>42
    Live Births48.0%41.0%35.7%19.9%5.7%
    Number of cycle starts506459459241209
    Singleton Births47.6%40.7%34.6%18.7%5.7%
  • What is the chance of Live Birth from Frozen Transer, not including the first intended transfer or occuring more than 12 months after retrieval?
    Age of Women<3535 - 3738 - 4041 - 42>42
    Live Births44.0%52.2%46.5%45.7%37.8%
    Number of thaw procedures3522682609498
    Singleton Births42.6%50.7%46.2%45.7%37.8%
  • What is the chance of live birth per transfer with a PGT-A screened embryo?
    Age of Women<3535 - 3738 - 4041 - 42>42
    Live Births52.6%53.6%52.9%53.3%58.8%
    Number of transfer81254138610517

The RMA Difference: IVF Success Rates Highlights

RMA of New York’s IVF success rates exceed national averages for all age groups and cycle types. What do RMA of New York IVF success rates mean for you and your personal family-building goals?

Here are key takeaways and highlights from RMA of New York’s 2021 SART data:

  • Many of our patients have live births within the first year of being a patient at RMA of New York. The SART Live Births per New Patient table shows the overall live birth rate for patients who are new to the clinic during the reporting year. Live Births per New Patient by age:
    • Under the age of 35: 76.6% live birth rate per new patient (8.1 percentage points above the national average)
    • Ages 35-37: 71.1% live birth rate per new patient (12.2 points above the national average)
    • Ages 38-40: 60.6% live birth rate per new patient (18 points above the national average)
    • Ages 41-42: 35.4% live birth rate per new patient (11.9 points above the national average)
    • Over the age of 42: 10.9% live birth rate per new patient (3.8 points above the national average)
  • RMA of New York’s cumulative live birth rate is above the national average by as much as 16.4 points (ages 38-40). The SART Live Birth Rate per Intended Egg Retrieval (All Embryo Transfers) reflects the chance of achieving a live birth after a fresh or frozen embryo transfer within a year of cycle initiated for egg retrieval. Cumulative live birth rate by age:
    • Under the age of 35: 64.2% live birth rate (10.3 points above the national average)
    • Ages 35-37: 53.4% live birth rate (12.9 points above the national average)
    • Ages 38-40: 42.4% live birth rate (16.4 points above the national average)
    • Ages 41-42: 21.8% live birth rate (8.5 points above the national average)
    • Over the age of 42: 7.1% live birth rate (3.1 points above the national average)
  • RMA of New York patients under the age of 35 have a live birth following their first embryo transfer nearly half of the time (48%). RMA of New York’s success rate for this category is as high as 14.6 points above the national average (ages 38-40). The SART Live Birth Rate per Intended Egg Retrieval (First Embryo Transfer) reflects the outcome of a patient’s first embryo transfer using either fresh or frozen embryos. Live birth rate per first embryo transfer by age:
    • Under the age of 35: 48.0% live birth rate per first embryo transfer (8.2 points above the national average)
    • Ages 35-37: 41% live birth rate per first embryo transfer (10.1 points above the national average)
    • Ages 38-40: 35.7% live birth rate per first embryo transfer (14.6 points above the national average)
    • Ages 41-42: 19.9% live birth rate per first embryo transfer (8.4 points above the national average)
    • Over the age of 42: 5.7% live birth rate per first embryo transfer (2.1 points above the national average)
  • PGT-A tested embryos lead to a higher live birth rate in every age group, when compared to unscreen embryos.
  • In fact, the chance of a live birth per transfer with a PGT-A tested embryo is above 52% for every age group.

FAQs: Fertility Treatment Success Rates

  • SART emphasizes the delivery of a child (rather than a positive pregnancy test) as the main outcome of interest. RMA of New York’s cumulative live birth rate per intended egg retrieval by age group is as follows:

    • Under the age of 35: 64.3%
    • Ages 35-37: 53.4%
    • Ages 38-40: 42.4%
    • Ages 41-42: 21.8%
    • Over the age of 42: 7.1%

  • Age often has the greatest impact on IVF success rates. Younger women tend to have a greater quantity of healthy eggs (known as ovarian reserve). The process of IVF treatment includes using injectable fertility medications to stimulate the ovaries to mature multiple eggs in order to fertilize those eggs and create embryos for pregnancy. Typically, in an IVF cycle, the greater the number of healthy eggs to be matured and fertilized to create embryos, the greater the chance of pregnancy success. At your initial consultation, your RMA of New York physician will review your medical history and fertility testing results to help inform your unique treatment plan and discuss your chance of conception given different treatment options. There is no way to know with complete certainty how a patient will respond to fertility medications or if she will conceive in a given treatment cycle, but fertility specialists can make reasonable predictions based on experience treating patients with similar characteristics.

  • IUI is a low-tech fertility treatment that is successful for many patients. SART, the organization that audits IVF success rates, does not provide success rate data for IUI. The RMA of New York fertility team can discuss our IUI treatments, and factors that affect success, including healthy sperm, eggs, and uterus. As with IVF, age, medical and genetic conditions, as well as lifestyle and other factors influence IUI success rates.

  • To increase the chances of achieving a successful pregnancy, especially in women in their late 30s to early 40s, it is important to have information about the genetic makeup of the embryos. Leading IVF clinics offer preimplantation genetic testing (PGT), which is the ability to biopsy a few cells from the blastocyst stage of the embryo and test the genetic competence. Note: Since it takes about two weeks to receive PGT testing results, embryos are retrieved, tested, then frozen and utilized in a subsequent cycle. Clinics that routinely utilize PGT testing may have SART data that reflects a lower “pregnancy rate per cycle initiated,” but a high “pregnancy rate per transfer.”

    SART reported the following data for RMA of New York in 2021:

    • Under the age of 35: 52.6% live birth rate per embryo transfer with PGT-A tested embryos, compared with 41.9% for unscreened embryos.
    • Ages 35-37: 53.6% live birth rate per embryo transfer with PGT-A tested embryos, compared with 36.5% for unscreened embryos.
    • Ages 38-40: 52.8% live birth rate per embryo transfer with PGT-A tested embryos, compared with 21.5% for unscreened embryos.
    • Ages 41-42: 53.3% live birth rate per embryo transfer with PGT-A tested embryos, compared with 19.2% for unscreened embryos.
    • Over the age of 42: 58.8% live birth rate per embryo transfer with PGT-A tested embryos, compared with 5.1% for unscreened embryos.

    Improvement in pregnancy success rates between PGT-A tested embryos and unscreened embryos is most notable in patients of advanced maternal age, since embryos created with eggs from older patients tend to be at greater risk for chromosomal abnormalities. PGT-A helps your fertility specialist to identify the healthiest embryo for successful pregnancy.

  • SART reported the following Live Birth Rate per First Embryo transfer data for RMA of New York in 2021:

    • Under the age of 35: 48.0% live birth rate per first embryo transfer
    • Ages 35-37: 41% live birth rate per first embryo transfer
    • Ages 38-40: 35.7% live birth rate per first embryo transfer
    • Ages 41-42: 19.9% live birth rate per first embryo transfer
    • Over the age of 42: 5.7% live birth rate per first embryo transfer

  • SART reports pregnancy success rates for cycles using donor eggs. In 2021, RMA of New York performed as follows:

    • Fresh donor eggs: 58.3% live birth rate
    • Frozen donor eggs: 53.6% live birth rate
    • Thawed embryos: 44.5% live birth rate

  • RMA of New York embryology laboratories, led by a team of top embryologists and fertility specialists, have helped countless patients become parents by utilizing state-of-the-art technologies that set the standard for embryology laboratories around the world. Our physicians’ research is regularly published in leading medical journals, and many are pioneers in the field of reproductive medicine, making significant contributions to research and to the field’s understanding and application of the latest assisted reproductive techniques. RMA of New York, in partnership with the Icahn School of Medicine at Mount Sinai, proudly trains the next generation of fertility specialists through its Reproductive Endocrinology and Infertility Fellowship Program. The program focuses on the latest assisted reproductive technology, advanced reproductive surgery, and cutting-edge research in reproductive medicine, embryology, and genomic medicine.

  • Here are some of the terms used in the SART data, defined:

    Intended egg retrieval: when a person starts an ovarian stimulation cycle with the goal of retrieving eggs. It includes people whose cycles were canceled or whose retrieval did not result in any eggs.

    New patient: patients who are new to the clinic and starting their first cycle for retrieval of their own eggs during the reporting year. SART reports on the outcomes of these patients within the year, regardless of how many or the types of cycles the patients undergo.

    The outcome of the first embryo transfer is called the primary outcome.
    If the primary outcome was negative, the outcome of any additional frozen embryo transfers is called the subsequent outcome.

    Success: SART emphasizes the delivery of a child (rather than a positive pregnancy test) as the main outcome of interest.

Helpful Resources on Understanding IVF Success Rates

Our website and social media channels provide further insights from our team of fertility specialists on IVF success rates and understanding SART data.

View All Posts

Get Started

It’s never too early to learn about your fertility and reproductive options.

Make An Appointment

Have questions?
We can help.

Patient-centric reproductive medicine is our specialty, and we look forward to answering any questions you may have.

Contact New Patient Concierge